Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Kessler leaving UCSF, ICOC

David Kessler said on Friday that his appointment as dean of the UCSF School of

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE